Thailand Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Thailand Diabetes Care Drugs Market is segmented into Drugs (Oral Anti-diabetic Drugs, Insulin, Non-insulin Injectable Drugs, and Combination Drugs). The report offers the market size in value terms in USD for all the abovementioned segments.

Thailand Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Thailand Diabetes Care Drugs Industry Overview

The diabetes drugs market is Semi consolidated, with few significant generic players. A few major players, like Novo-Nordisk, Sanofi, AstraZeneca, and Bristol Myers Squibb, dominate the insulin drugs and Sglt-2 drugs market. The market for oral drugs, like Sulfonylureas and Meglitinides, comprises more generic players. The intensity of competition among the players is high, as each player is striving to develop new drugs and offer them at competitive pricing. Furthermore, players are tapping into new markets to increase their market shares, especially in emerging economies where the demand is very high compared to the supply.

Thailand Diabetes Care Drugs Market Leaders

  1. Eli Lilly

  2. Boehringer Ingelheim

  3. Astrazeneca

  4. Sanofi

  5. NovoNordisk

  6. *Disclaimer: Major Players sorted in no particular order
Thailand Diabetes Care Drugs Market Concentration